These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10358385)

  • 21. Impact of scar thickness on the assessment of viability using dobutamine echocardiography and thallium single-photon emission computed tomography: a comparison with contrast-enhanced magnetic resonance imaging.
    Nelson C; McCrohon J; Khafagi F; Rose S; Leano R; Marwick TH
    J Am Coll Cardiol; 2004 Apr; 43(7):1248-56. PubMed ID: 15063438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of hibernating myocardium in patients with heart insufficiency].
    La Canna G; Agricola E; Alfieri O
    Ital Heart J Suppl; 2000 Oct; 1(10):1289-97. PubMed ID: 11068710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium in ischemic cardiomyopathy.
    Narula J; Dawson MS; Singh BK; Amanullah A; Acio ER; Chaudhry FA; Arani RB; Iskandrian AE
    J Am Coll Cardiol; 2000 Nov; 36(6):1913-9. PubMed ID: 11092664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Potential and limitation of myocardial perfusion scintigraphy for detection of viability].
    Knapp WH
    Nuklearmedizin; 1995 Jun; 34(3):118-26. PubMed ID: 7630745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of the assessment of myocardial viability: evaluation with positron emission tomography 18F-FDG].
    Alexánderson Rosas E; Lamothe Molina PA; Iñarra Talboy F; Calleja Torres R; Martínez García A; Ochoa López JM; Meave González A
    Arch Cardiol Mex; 2008; 78(4):431-7. PubMed ID: 19205553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. F-18 fluoro deoxyglucose SPECT for assessment of myocardial viability.
    Fitzgerald J; Parker JA; Danias PG
    J Nucl Cardiol; 2000; 7(4):382-7. PubMed ID: 10958281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [F-18 fluorodeoxyglucose for diagnosis of myocardial viability: applications in clinical practice].
    Graf S; Porenta G
    Wien Med Wochenschr; 2002; 152(11-12):289-92. PubMed ID: 12138658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dobutamine stress echocardiography for the detection of coronary artery disease and viable myocardium.
    Kishida H; Kusama Y; Homma H
    Jpn Heart J; 1997 Mar; 38(2):151-61. PubMed ID: 9201103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Echocardiography for the assessment of myocardial viability.
    Lualdi JC; Douglas PS
    J Am Soc Echocardiogr; 1997 Sep; 10(7):772-80. PubMed ID: 9339433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perfusion-contraction mismatch during inotropic stimulation in hibernating myocardium.
    Sambuceti G; Giorgetti A; Corsiglia L; Marini C; Schneider-Eicke J; Brunelli C; Marzullo P; L'Abbate A; Capponnetto S; Parodi O
    J Nucl Med; 1998 Mar; 39(3):396-402. PubMed ID: 9529281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of hibernating myocardium in patients with ischemic heart disease.
    Castro PF; Bourge RC; Foster RE
    Am J Med; 1998 Jan; 104(1):69-77. PubMed ID: 9528722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Postinfarction hibernating myocardium].
    Montalescot G; Faraggi M; Drobinski G; Le Guludec D; Grosgogeat Y; Thomas D
    Arch Mal Coeur Vaiss; 1994 Jan; 87(1):79-84. PubMed ID: 7811155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial viability: contractile reserve or cell membrane integrity?
    Dilsizian V
    J Am Coll Cardiol; 1996 Aug; 28(2):443-6. PubMed ID: 8800123
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability.
    Baer FM; Voth E; LaRosée K; Schneider CA; Theissen P; Deutsch HJ; Schicha H; Erdmann E; Sechtem U
    Am J Cardiol; 1996 Aug; 78(4):415-9. PubMed ID: 8752185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selecting patients with ischemic cardiomyopathy for medical treatment, revascularization, or heart transplantation.
    Beller GA
    J Nucl Cardiol; 1997; 4(2 Pt 2):S152-7. PubMed ID: 9115077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of wall motion improvement after coronary revascularization in patients with postmyocardial infarction: diagnostic value of dobutamine stress echocardiography and myocardial contrast echocardiography.
    Waku S; Ohkubo T; Takada K; Ishihara T; Ohsawa N; Adachi I; Narabayashi I
    J Cardiol; 1997 Oct; 30(4):197-203. PubMed ID: 9365857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
    Brunken RC; Mody FV; Hawkins RA; Nienaber CA; Phelps ME; Schelbert HR
    Herz; 1994 Feb; 19(1):28-41. PubMed ID: 8150412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated backscatter for the assessment of myocardial viability.
    Yamada S; Komuro K
    Curr Opin Cardiol; 2006 Sep; 21(5):433-7. PubMed ID: 16900004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI assessment of myocardial viability: comparison with other imaging techniques.
    Baer FM; Theissen P; Schneider CA; Kettering K; Voth E; Sechtem U; Schicha H
    Rays; 1999; 24(1):96-108. PubMed ID: 10358387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of myocardial viability by nuclear imaging techniques.
    Bax JJ; Poldermans D; Elhendy A; Boersma E; van der Wall EE
    Curr Cardiol Rep; 2005 Mar; 7(2):124-9. PubMed ID: 15717959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.